Drug makers betting on new combination products to tackle difficulties
Published: 2012-09-04 07:00:00
Updated: 2012-09-04 07:00:00
Generic manufacturing has long been a major source of revenue for most Korean pharmaceutical firms. That heavy reliance and their weak overseas presence caused them to shirk from drug development as it costs huge amounts of time and money with no assurance of success.
Reckoning the need for l...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
